RespireRx Pharmaceuticals Inc. announced has entered into two Demand Promissory Note and Warrant purchase agreement for private placement of $250,000 on May 22, 2023. The loan will bear interest rate of 10%. The transaction included participation from Arnold Lippa Family Trust of 2007 for Demand Promissory Note of $225,000 and a Warrant exercisable into 75,000,000 shares and Marc M. Radin Demand Promissory Note of $25,000 and a Warrant exercisable into 8,333,333 shares.

The securities are issued pursuant to regulation D.